Computed Tomography (CT) Devices Market: Shift Toward Non-Invasive and Preventive Diagnostics to Drive Market Growth to US$ 25.17 Billion by 2031

As per the latest market research by Business Market Insights (BMI), the research report "Computed Tomography (CT) Devices Market Size and Forecast (2025–2031)" forecasts how the market is set to surge 37.5% by 2031. The report underscores that the global CT devices market is advancing with AI integration, spectral imaging, and low-dose technologies that enhance diagnostic accuracy while ensuring patient safety. These systems enable faster workflows, superior image quality, and wider clinical use across oncology, cardiology, and emergency care. Rising demand for non-invasive, real-time diagnostics positions CT as a cornerstone of modern healthcare delivery.

The report forecasts the market to expand from US$ 18.30 Billion in 2024 to US$ 25.17 Billion registering a robust CAGR of 4.66% over the 2025–2031 period.

The computed tomography (CT) devices market is growing as hospitals and clinics depend more on advanced imaging to find and treat diseases quickly. The rise in chronic illnesses such as cancer, heart problems, and brain disorders is increasing the need for fast and reliable diagnostic tools, and CT scans remain one of the most trusted options.

New technologies are also shaping the market. Features like low-dose scanning, dual-energy CT, and AI-based image improvements give clearer pictures while lowering risks for patients. These upgrades make CT useful in many areas, including cancer care, heart and lung imaging, accident cases, and regular health checks. The trend of smaller and portable CT machines is also popular because they allow doctors to provide imaging in emergency rooms, rural areas, and smaller clinics. With growing investment in healthcare around the globe, CT devices have become more vital to medical care, supporting faster diagnoses and better treatment outcomes.

Overview of report findings

Market Growth

The computed tomography (CT) devices market is projected to grow from US$ 18.30 Billion in 2024 to US$ 25.17 Billion, registering a compound annual growth rate (CAGR) of 4.66% between 2025 and 2031.

The computed tomography (CT) devices market is driven by rising burden of chronic disease such as cardiovascular disorders, cancer, respiratory diseases, and neurological conditions, technological advancements, expanding point-of-care applications, aging populations, and growing healthcare infrastructure in emerging economies, enhancing accessibility and clinical efficiency.

Shift Toward Non-Invasive and Preventive Diagnostics

Demand for non-invasive imaging systems, and preventative health is a major driver for CT systems. Patients are increasingly choosing diagnostic methods that minimize discomfort, avoid surgical risks, and deliver results quickly. CT scans can offer high-quality images without invasive procedures. The role of CT imaging changes and expands beyond diagnostic imaging. CT imaging is steadily reshaping the landscape of diagnostic imaging by expanding into screening programs and preventive health check-ups. Its growing use in detecting lung, cardiovascular, and cancer conditions at an early stage enables timely intervention, reducing complications and improving long-term health outcomes. Both governments and private healthcare providers are increasingly promoting preventive screening as a cost-effective strategy that lowers the overall burden on healthcare systems. This shift is fueling the adoption of CT systems across hospitals, diagnostic centers, and smaller clinics.

Rising Burden of Chronic and Lifestyle Diseases

Cardiovascular disease, cancer, lung disease, and neurological disease are becoming more common globally, largely because of older population demographic, sedentary lifestyles, and poor diets. Often, these diseases need to be diagnosed quickly and accurately, so healthcare providers can make treatment decisions and improve patient outcomes. CT scans can meet this need, since they can provide detailed cross-section images rapidly, which help clinicians detect abnormalities sooner and effectively plan treatment interventions. As an example, CT is often used to assess coronary artery blockages, locate and identify tumors, assess lung infections, or monitor brain injuries. The ability of CT imaging to provide quick, non-invasive, and reliable diagnostic information makes it indispensable in managing chronic disease cases. As healthcare systems shift their focus toward timely and precise diagnoses, the use of CT will increase further across both developed and developing markets.

Geographic Insights

North America holds the largest share of the global computed tomography devices market, supported by advanced healthcare infrastructure, widespread use of cutting-edge imaging technologies, and a highly skilled clinical workforce. Favorable reimbursement policies, and strong support for preventive health further encourage adoption of such diagnostics imaging modalities. Demand is particularly strong in cardiology, oncology, and trauma. The region is also at the leading edge of innovation, with a greater integration of artificial intelligence and low-dose imaging methods into CT systems.

Europe is the second largest market, with a strong adoption of non-invasive diagnostics, and a strong regional network of imaging centers. Specific countries such as Germany, France, and the UK are leading the adoptiong of high-resolution and portable CT systems. Regular investment in healthcare, and the presence of several noteworthy global medical device manufacturers bolster the region.

Asia Pacific is the fastest-growing market, driven by a large patient base, rapid healthcare expansion, and wider access to modern diagnostics. Government programs, medical tourism, and rising awareness of early disease detection are fueling adoption in China, India, and Southeast Asia.

Market Segmentation

• By product type, the computed tomography (CT) devices market is segmented into traditional CT scanners, multi-slice CT scanners, portable CT scanners and cone beam CT. The multi-slice CT scanners segment dominated the market in 2024.
• By portability, the computed tomography (CT) devices market is segmented into stationary CT scanners and portable CT scanners. The stationary CT scanners segment dominated the market in 2024.
• By technology, the computed tomography (CT) devices market is segmented into low-slice CT scanners, mid-slice CT scanners, high-slice CT scanners and cone beam CT. The mid-slice CT scanners segment dominated the market in 2024.
• By application, the computed tomography (CT) devices market is segmented into oncology, cardiology, neurology, orthopedics, urology, gynecology, maxillofacial and others. The oncology segment dominated the market in 2024.
• By end user, the market is segmented into hospitals, specialty clinics, diagnostics imaging centers, ambulatory surgical centers and others. The hospitals segment held the largest share of the market in 2024.

Competitive Strategy & Development

Key Players: The computed tomography (CT) devices market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. GE HealthCare
2. Siemens Healthineers AG
3. FUJIFILM Holdings Corporation
4. Canon Inc.
5. Koninklijke Philips N.V.
6. Shanghai United Imaging Healthcare Co., LTD
7. Samsung Healthcare
8. IDETEC MEDICAL IMAGING
9. NeuroLogica Corp.
10. Neusoft Medical Systems

Trending Topics: Portable Computed Tomography (CT) Devices, Photon-counting CT,

Global Headlines

• " Samsung launched mobile CT system – In August 2025, Samsung India, in collaboration with NeuroLogica, launched its next-generation mobile CT product portfolio, including CereTom Elite, OmniTom Elite, and BodyTom 32/64. These AI-powered systems are designed for use in ICUs, operating rooms, and emergency departments, offering advanced imaging without the need for extensive infrastructure.
• " Canon Medical Systems introduced Aquilion ONE and Aquilion Serve SP – In November 2023, Canon Medical Systems introduced the Aquilion ONE / INSIGHT Edition and Aquilion Serve SP at RSNA. These flagship CT systems offer high-throughput scanning and enhanced imaging capabilities, reinforcing Canon’s leadership in diagnostic imaging.

Conclusion

The market for computed tomography devices is expected to expand gradually due to the increasing number of chronic diseases like cancer, cardiovascular diseases, and neurological diseases, coupled with the increasing demand for rapid and precise diagnosis. CT systems are gaining importance as non-invasive imaging modalities offering high-resolution cross-sectional images, which are becoming mandatory in most of the hospitals, clinics, and emergency centers. Innovations in technology like low-dose imaging, dual-energy CT, AI-driven reconstruction, and light systems are also broadening the breadth of applications, enhancing both patient safety and diagnostic effectiveness. Although high expense and human resource shortages are a problem in some areas, the market is progressing well with high R&D support, product development, and strategic alliances between top players. These considerations are making CT scanners stay at the center of contemporary imaging routines, facilitating earlier disease identification, improved treatment planning, and enhanced healthcare outcomes.